Sentences with phrase «developing other cancers»

Are you a breast cancer survivor concerned about hormone replacement therapy or the risk of developing other cancers?

They also found that members of these families appeared to be at higher risk of developing other cancers including melanoma and endometrial cancer.

Dr Andreas Behren, who led the ONJCRI research team, said that although extremely rare, it couldn't be predicted which melanoma patients might develop other cancers as a result of their treatment.

Not exact matches

Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward - looking statements include, among others, the following: our ability to successfully and profitably market our products and services; the acceptance of our products and services by patients and healthcare providers; our ability to meet demand for our products and services; the willingness of health insurance companies and other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from other cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 1cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 1Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 1cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 10 - Q.

It has been relegated to many narrow use cases involving pattern recognition and prediction (some of which are very valuable and useful, such as improving cancer detection, identifying financial risk and fraud, and other high performance computing applications), but it has not developed a general «understanding» of human interactions, human emotions, speech patterns and human responses to information.

«The success of Cologuard also positions us to develop tests that facilitate the early, accurate detection of other forms of cancer.»

The two companies plan to develop drugs to fight multiple cancer types, either alone or in combination with their other cancer treatments.

Maastricht, The Netherlands, 1 November 2017 — Cristal Therapeutics, a clinical stage biopharmaceutical company developing targeted nanomedicines for the treatment of cancer and other diseases with high unmet patient need, announced today that it has begun a Phase 1b...

Two other reports in the same issue of Cancer Causes and Control suggest that children born to mothers who eat at least one hot dog per week during pregnancy have double the normal risk of developing brain tumors, as do children whose fathers ate hot dogs before conception.

On the other hand, women who breastfeed appropriately are unlikely to develop breast cancer and ovarian cancer.

In August of 2009, researchers reported that women who have a mother, sister, or other type of close relative who suffered from breast cancer cut their risk for developing the disease by 59 % if they breastfeed their babies.

According to the article, one woman had a 15 - year history of twice monthly UV nail light exposure while the other woman had exposure eight times in one year before developing skin cancer.

Moms who breastfeed for a total of 12 months through their life or participate in extended breastfeeding for their baby's first year of life or longer may have a decreased risk of developing breast or ovarian cancer, heart disease, diabetes, rheumatoid arthritis, and other diseases.

One study cites a 26 — 31 % decrease in the development of breast cancer in females who had been breastfed as babies; if you or she takes no other preventive measures against breast cancer, breastfeeding her alone sets your baby girl up for a nearly 1/3 lower likelihood of developing breast cancer later in her life (Freudenheim et al., 1994).

Several years ago, after an acquaintance asked me if I'd heard about the controversy, I Googled «cow's milk» and «kids» and a new world opened up to me — one that hysterically warned me that cow's milk would cause my child to develop diabetes, obesity, and cancer, among other lovely things.

Many women who develop breast cancer have no known risk factors other than simply being women.

But it's not clear why some people who have no risk factors develop cancer, yet other people with risk factors never do.

Unlike other forms of breast cancer, women with inflammatory breast cancer do not develop lumps in the breast.

Just like the late law professor, the health status of the flag - bearer of the New Patriotic Party, Nana Akufo - Addo has also been questioned by some of his opponents who claim he is medically unfit to be elected president of Ghana The Africa Watch Magazine last month published a supposed medical records of Nana Akufo - Addo claiming he has developed acute cancer among other diseases; something his campaign team and doctor have since rejected.

«The Town of Batavia and the City of Batavia could go to a fire, fighting alongside each other, and if a firefighter develops cancer, he is covered with his cancer, any cancer he gets.

However, it is important to remember that many women will never develop breast cancer in the other side.

In addition to HPV infection, other factors that increase a woman's risk of developing cervical cancer include: not having regular Pap tests; not following up with your health care provider if you had a Pap test result that is not normal; having HIV (the virus that causes AIDS); having another condition that makes it hard for your body to fight off health problems; and smoking.

Specifically, «The bill expands coverage to volunteer firefighters with at least five years of service who developed lymphoma or leukemia after their service, and coverage for volunteer firefighters with at least 10 years of service who develop stomach, skin, breast, prostate and other reproductive cancers after their service,» according to information from Senator Jacobs» office.

If a woman is positive for HPV genotypes 16 or 18, which convey the greatest risk of developing cervical cancer precursor lesions in the next three years, she should be referred for a colposcopy (an illuminated, magnified examination of the cervix and other genital tissue for premalignant or malignant lesions).

By combining this strategy with cancer cell - targeting materials, we should be able to develop a therapy for glioblastoma and other challenging cancers in the future.»

While pursuing her project on how environmental contaminants and oxidative stress cause lung cancer, Gelhaus complemented her postdoctoral training by spending some time with other PIs at Penn. «She has worked hard to develop skills that are independent of those available in my own laboratory while working on a project that is central to my research program,» Blair writes in an e-mail to Science Careers.

«This finding,» Villanueva said «opens the door to developing new biomarkers and new therapeutic strategies exploiting these characteristics of exosomes in breast tumors, and other tumors such as ovarian and endometrial cancer among others.»

The researchers studied whether family members who have not inherited the mutation have any higher than normal risk of developing melanoma or other cancers.

Such a lag time, says Hahn, could allow cancer cells to develop resistance to a drug by finding some other way to maintain their telomeres.

Since molecules that target CCR3 have already been developed by the pharmaceutical industry for other diseases, the researchers are now hoping to explore this new therapeutic pathway, which could reduce the aggressiveness of prostate cancer in obese patients.

«It is expected that this study will lay the foundation for developing a new class of potent and effective cancer therapies and the development of reagents targeting epigenetic events in immune - mediated diseases as well as other epigenetically - influenced diseases,» said Alani, who also is chief of dermatology at Boston Medical Center.

The scientists have shown that, in all cancers, a sort of «identity crisis» is observed in cancerous cells: in the organs or tissues in which a tumor develops, genes specific to other tissues or to other stages of the development of the organism express themselves in an aberrant manner.

Although other cancer - associated proteins have been successfully attacked with targeted therapies in recent years, the myc protein has continued to elude efforts to develop drugs that target it.

Gene variants have been linked to elevated risks for disorders from Alzheimer's disease to breast cancer, and they may help explain why, for example, some smokers develop lung cancer whereas many others don't.

A team under Professor Scheffler, consisting of researchers from the Bonn University Hospital, the Life & Brain Center, The German Consortium for Translational Cancer Research, Tufts University Boston / Massachusetts, and other institutes in the USA, has now developed a new method that is expected to combat such complex brain tumors better.

«One criticism of the PARP drugs is they are not active in patients who have developed resistance to other therapies, but we found veliparib appears to be effective in some platinum - resistant patients with recurrent or persistent disease,» said Robert L. Coleman, MD, lead author of the study and professor and vice chair of clinical research at the University of Texas MD Anderson Cancer Center, Houston.

«We know that patients with BRCA mutations are at high risk for developing breast, as well as pancreatic, ovarian, prostate and other cancers, and we have learned over time that BRCA plays a very important role in DNA damage repair.

Women with a family history of two or more immediate family members (mother, sister, daughter) with breast or ovarian cancer or with a positive genetic test for mutations in the BRCA1 or BRCA2 genes may be advised to consider having both breasts removed, because they are at high risk of a new cancer developing in the other breast.

Since nitrites are powerful carcinogens, Duesberg thought this explained why gay men frequently developed the cancer Kaposi's sarcoma but other risk groups, such as hemophiliacs and heterosexual drug abusers, rarely did.

It implies that an EBV vaccine, if it were ever developed, could prevent not just kissing disease, but many other disorders, similar to the way the human papillomavirus vaccine reduces cervical cancer risk.

Mutations in the gene predispose to colon cancer and cancer of the uterus, and increase the risk of developing some other, rare tumours.

Diabetes is linked to an increased risk of developing cancer, and now researchers have performed a unique meta - analysis that excludes all other causes of death and found that diabetic patients not only have an increased risk of developing breast and colon cancer but an even higher risk of dying from them.

How could that affect your chance of developing cancer later in life, and how does that compare to the risk from other common activities?

Cancer stem cells are strongly associated with the growth and recurrence of all cancers and are especially difficult to eradicate with normal treatment, which also leads to tumours developing resistance to other types of therapy.

They have also developed other analogues that show very good inhibitory effects on cancer stem cells.

White and colleagues will work with other collaborators at the Cancer Institute to develop early - phase patient clinical trials based on the findings from this study in the near future.

Drugs that inhibit the activity of enzymes called histone deacetylases (HDACs) are being widely developed for treating cancer and other diseases, with two already on the market.

The process, which located a genetic site for the most common form of prostate cancer, has potential for developing precision therapy for other cancers, such as breast, brain and colorectal, say researchers at The University of Texas MD Anderson Cancer Ccancer, has potential for developing precision therapy for other cancers, such as breast, brain and colorectal, say researchers at The University of Texas MD Anderson Cancer CCancer Center.

Their work helped inspire others to use genetics to predict cancer risks and develop personalized cancer treatments.

«Dormant disseminated tumors can be ticking time bombs, but now that we know some of the triggers, it may be possible to develop therapies to ensure that disseminated cancer cells remain in a dormant state, or other therapies that eradicate these cells before they form full - blown metastases.»